Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
News|Slideshows|June 15, 2024
Small Doses: June 10 to June 14
Author(s)Lauren Massaro
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Advertisement
Don’t get left behind: Sign up today for our
Advertisement
Related to this article
James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.
ACIP changes, new court rulings, and coverage gaps threaten vaccines, pharmacists’ reimbursement, and children's access through Vaccine For Children.
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.
Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
Advertisement
Advertisement
Trending on Drug Topics
1
Nicotine Pouches Create Opportunity for Pharmacist Counseling
2
Worth a Shot: How ACIP Changes Might Impact Vaccine Access, Coverage
3
FDA Approves Finerenone for Chronic Kidney Disease With Type 1 Diabetes
4
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
5